SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$872K−9.3%Oct 8
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · Chief Financial Officer

$329K−14.4%Oct 8
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · President, R&D

$162K−2.1%Sep 9
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · Chief Financial Officer

$336K−12.6%Sep 9
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$913K−8.5%Sep 9
RLAYSell

Relay Therapeutics, Inc.

Peter Rahmer · Insider

$90K−2.0%Aug 28
RLAYSell

Relay Therapeutics, Inc.

SVF Pauling (Cayman) Ltd · 10% owner

$116.4M−21.5%Aug 28
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$980K−7.8%Aug 18
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · Chief Financial Officer

$350K−11.2%Aug 18
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · Chief Financial Officer

$27K−0.9%Jul 30
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · President, R&D

$42K−0.5%Jul 30
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · President, R&D

$162K−2.1%Jul 8
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$944K−7.3%Jul 8
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · Chief Financial Officer

$331K−10.0%Jul 8
RLAYSell

Relay Therapeutics, Inc.

Peter Rahmer · Insider

$955K−18.1%Jul 2
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · Chief Financial Officer

$3.2M−51.3%Jun 24
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · President, R&D

$1.6M−18.3%Jun 24
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$228K−8.0%May 14
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$257K−8.0%Apr 9
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$178K−7.0%Mar 11
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$120K−6.0%Jan 29
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$167K−5.0%Jan 29
RLAYSell

Relay Therapeutics, Inc.

Peter Rahmer · Insider

$100K−5.0%Jan 29
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$338K−3.0%Jan 7
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$55K−3.0%Oct 30
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$48K−2.0%Oct 1
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$92K−3.0%Jul 31
RLAYSell

Relay Therapeutics, Inc.

Peter Rahmer · Insider

$353K−10.0%Jul 31
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$791K−4.0%Jul 29
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$58K−3.0%Jul 1
RLAYSell

Relay Therapeutics, Inc.

Peter Rahmer · Insider

$542K−16.0%Jun 5
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$31K−1.0%Jan 31
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$32K−1.0%Jul 31
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$32K−1.0%Jun 1
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$882K−3.0%Feb 9
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$31K−1.0%Jan 31
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$1.7M−6.0%Jan 19
RLAYSell

Relay Therapeutics, Inc.

Brian Adams · General Counsel

$200K−16.0%Jan 13
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$843K−3.0%Nov 10
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$221K−10.0%Nov 1
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$884K−3.0%Oct 13
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$179K−8.0%Oct 4
RLAYSell

Relay Therapeutics, Inc.

Sanjiv Patel · President and CEO

$1.0M−3.0%Sep 15
RLAYSell

Relay Therapeutics, Inc.

Thomas Catinazzo · CFO

$788K−33.0%Sep 8
RLAYSell

Relay Therapeutics, Inc.

Mark Murcko · Director

$749K−2.0%Sep 8
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$750K−22.0%Sep 8
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$125K−5.0%Sep 2
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$187K−8.0%Sep 1
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$375K−14.0%Aug 25
RLAYSell

Relay Therapeutics, Inc.

Donald A Bergstrom · Pres, R, D

$160K−8.0%Aug 8

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.